News
Bravecto Quantum is the first FDA-approved drug that treats and prevents flea and tick infestations on dogs for a duration of ...
James Bascharon started his pet supplement company out of his garage. He sold it to a private equity firm for millions.
Rahway: Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., ...
Rahway, New Jersey Saturday, July 12, 2025, 09:00 Hrs [IST] ...
The U.S. Food and Drug Administration has approved Bravecto Quantum, a new shot that protects dogs six months or older ...
The Food and Drug Administration has approved a first of its kind, once-yearly shot designed to protect dogs from fleas and ...
A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the ...
Fluralaner for extended-release injectable suspension (Bravecto Quantum) is also indicated for treatment of lone star tick in ...
Merck's animal health division received Food and Drug Administration approval for its once-yearly injectable flea-and-tick treatment for dogs. Merck Animal Health said Thursday it expects its Bravecto ...
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., ...
Merck & Co. Inc. (NYSE:MRK) is one of the most undervalued NYSE stocks to buy now. On July 9, Merck announced its acquisition ...
Merck is set to announce its second-quarter results later this month, and analysts anticipate double-digit earnings dip.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results